(Q81160402)
Statements
No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma (English)
Louise E McGreavey
Faye Turner
Gillian Smith
Katherine Boylan
D Timothy Bishop
David Forman
C Roland Wolf
Jennifer H Barrett
Colorectal Cancer Study Group
1 October 2005